Abstract:You have accessJournal of UrologyInfections/Inflammation/Cystic Disease of the Genitourinary Tract: Interstitial Cystitis1 Apr 2016MP72-20 INHIBITION OF ICAM-1 AS A NOVEL THERAPEUTIC STRATEGY IN A RAT MODEL OF NON-BACTERIAL CYSTITIS RESEMBLING INTERSTITIAL CYSTITIS. xiang zhang, yuan xu, chao he, zhoujun shen, and yuan shao xiang zhangxiang zhang More articles by this author , yuan xuyuan xu More articles by this author , chao hechao he More articles by this author , zhoujun shenzhoujun shen More articles by this author , and yuan shaoyuan shao More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1633AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To evaluate the role of intercellular adhesion molecule 1 (ICAM1) as a therapeutic target for rat model of non-bacterial cystitis resembling interstitial cystitis (IC). METHODS Female Sprague-Dawley rats were divided into 6 groups. Control group (group 1) was administered with intravesical instillation of saline. Group 2-6 using cystitis model were constructed by intraperitoneal cyclophosphamide combined with intravesical protamine/lipopolysaccharide. In group 3 and 6, hyaluronic acid (HA) or anti-ICAM-1 antibody (AIA) were instilled intrvesically respectively. In group 4 and 5, celecoxib or aprepitant were introduced to rats by gavage respectively. Bladder samples were harvested for histological evaluation including inflammation grade, mast cell counts and measurement of purinergic receptors (P2X3 and P2Y2), PGE2 and E-series prostaglandin receptors (EP1 and EP2), tumor necrosis factor alpha (TNF-a), ICAM-1 and neurokinin-1 receptor (NK1R). RESULTS Significant increase of bladder inflammation grade and mast cell counts were observed in cystitis model, accompanied with higher expression of P2X3/P2Y2, PGE2 and EP1/EP2, TNF-a, NK1R and ICAM-1. AIA significantly decreased inflammation grade and mast cell counts, while other treatments had weaker or no effect. Aprepitant attenuated expressions of all cytokines and receptors except P2X3 to some degree. AIA could inhibite the elevation of all cytokines and receptors significantly stronger than any other drugs including aprepitant. Furthermore, the expressions of all involved cytokines and receptors in rat models receiving AIA became no difference to normal control. CONCLUSIONS Compared with HA, celecoxib or aprepitant, anti-ICAM-1 antibody showed remarkably superior effects in attenuating the severity of non-bacterial cystitis in rat model representing IC. ICAM-1 probably plays a critical role in the pathophysiological of PBS/IC and should be further investigated as a new therapeutic target. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e959-e960 Advertisement Copyright & Permissions© 2016MetricsAuthor Information xiang zhang More articles by this author yuan xu More articles by this author chao he More articles by this author zhoujun shen More articles by this author yuan shao More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

HO-1 alleviates neuroinflammation and cystitis-related symptoms in cyclophosphamide-induced cystitis via the SIRT1 pathway

Umbilical Cord Mesenchymal Stem Cells Overexpressing Heme Oxygenase-1 Promotes Symptoms Recovery in Cystitis Rats by Alleviating Neuroinflammation

Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis

Melatonin Improves Bladder Symptoms and May Ameliorate Bladder Damage Via Increasing HO-1 in Rats

Neuregulin-1-ErbB signaling promotes microglia activation contributing to mechanical allodynia of cyclophosphamide-induced cystitis.

Fosaprepitant improves cyclophosphamide-induced bladder damage by alleviating inflammatory response in mice

The serotonin(5-HT)2A receptor is involved in the hypersensitivity of bladder afferent neurons in cyclophosphamide-induced cystitis

[Optimization study of an animal model for interstitial cystitis/bladder pain syndrome based on the dose effect of cyclophosphamide]

Heme Oxygenase-1 Ameliorates Dextran Sulfate Sodium-induced Acute Murine Colitis by Regulating Th17/Treg Cell Balance

Effect of the neuropathic pain receptor P2X3 on bladder function induced by intraperitoneal injection of cyclophosphamide (CYP) in interstitial cystitis rats

PACAP/PAC1 Regulation in Cystitis Rats: Induction of Bladder Inflammation Cascade Leading to Bladder Dysfunction

Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis

Suppression of adenosine A2a receptors alleviates bladder overactivity and hyperalgesia in cyclophosphamide-induced cystitis by inhibiting TRPV1

Irisin alleviates chronic constriction injury-induced hyperalgesia and affective disorders in mice through NF-κB and Nrf2 signaling pathways

Specific Inhibition of ICAM-1 Effectively Reduces Bladder Inflammation in a Rat Model of Severe Non-Bacterial Cystitis

Phloroglucinol Protects the Urinary Bladder Via Inhibition of Oxidative Stress and Inflammation in a Rat Model of Cyclophosphamide-induced Interstitial Cystitis

MP72-20 INHIBITION OF ICAM-1 AS A NOVEL THERAPEUTIC STRATEGY IN A RAT MODEL OF NON-BACTERIAL CYSTITIS RESEMBLING INTERSTITIAL CYSTITIS.

Inhibiting the CB1 receptor in CIH-induced animal model alleviates colon injury

Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome

Icariin and Icaritin Ameliorated Hippocampus Neuroinflammation Via Inhibiting HMGB1-related Pro-Inflammatory Signals in Lipopolysaccharide-Induced Inflammation Model in C57BL/6 J Mice.

Spinal Cathepsin S promotes visceral hypersensitivity via FKN/CX3CR1/p38 MAPK signaling pathways